806 related articles for article (PubMed ID: 25086479)
21. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
23. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
Nakashima Y; Kubo T; Sugiura K; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kimura A; Doi YL; Kitaoka H
Circ J; 2020 Sep; 84(10):1846-1853. PubMed ID: 32830170
[TBL] [Abstract][Full Text] [Related]
24. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen P; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Hämäläinen L; Melin J; Kärkkäinen S; Peuhkurinen K; Nieminen MS; Laakso M; ; Kuusisto J
Ann Med; 2014 Sep; 46(6):424-9. PubMed ID: 24888384
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
Van Driest SL; Ackerman MJ; Ommen SR; Shakur R; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
Circulation; 2002 Dec; 106(24):3085-90. PubMed ID: 12473556
[TBL] [Abstract][Full Text] [Related]
26. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
Roncarati R; Latronico MV; Musumeci B; Aurino S; Torella A; Bang ML; Jotti GS; Puca AA; Volpe M; Nigro V; Autore C; Condorelli G
J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287
[TBL] [Abstract][Full Text] [Related]
27. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
28. [Mutations in genes for sarcomeric proteins].
Kimura A
Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
[TBL] [Abstract][Full Text] [Related]
29. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
[TBL] [Abstract][Full Text] [Related]
30. Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy.
Liu W; Liu W; Hu D; Zhu T; Ma Z; Yang J; Xie W; Li C; Li L; Yang J; Li T; Bian H; Tong Q
Am J Cardiol; 2013 Aug; 112(4):585-9. PubMed ID: 23711808
[TBL] [Abstract][Full Text] [Related]
31. Myocardial Deformation Analysis in
Höller V; Seebacher H; Zach D; Schwegel N; Ablasser K; Kolesnik E; Gollmer J; Waltl G; Rainer PP; Verheyen S; Zirlik A; Verheyen N
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680864
[TBL] [Abstract][Full Text] [Related]
32. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
[TBL] [Abstract][Full Text] [Related]
33. High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort.
Santos S; Marques V; Pires M; Silveira L; Oliveira H; Lança V; Brito D; Madeira H; Esteves JF; Freitas A; Carreira IM; Gaspar IM; Monteiro C; Fernandes AR
BMC Med Genet; 2012 Mar; 13():17. PubMed ID: 22429680
[TBL] [Abstract][Full Text] [Related]
34. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
35. Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy.
Wang S; Zou Y; Fu C; Xu X; Wang J; Song L; Wang H; Chen J; Wang J; Huan T; Hui R
Clin Cardiol; 2008 Mar; 31(3):114-8. PubMed ID: 18383048
[TBL] [Abstract][Full Text] [Related]
36. Genetic basis of end-stage hypertrophic cardiomyopathy.
Garcia-Pavia P; Vázquez ME; Segovia J; Salas C; Avellana P; Gómez-Bueno M; Vilches C; Gallardo ME; Garesse R; Molano J; Bornstein B; Alonso-Pulpon L
Eur J Heart Fail; 2011 Nov; 13(11):1193-201. PubMed ID: 21896538
[TBL] [Abstract][Full Text] [Related]
37. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
[TBL] [Abstract][Full Text] [Related]
38. Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.
Meyer T; Pankuweit S; Richter A; Maisch B; Ruppert V
Gene; 2013 Sep; 527(1):416-20. PubMed ID: 23816408
[TBL] [Abstract][Full Text] [Related]
39. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
[TBL] [Abstract][Full Text] [Related]
40. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
